PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson's Disease and Motor Disorders
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Long Term Effect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
13.07.2022 - TORONTO, July 13, 2022 (GLOBE NEWSWIRE) - PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, announced today that the United States Patent and Trademark Office ... Seite 1
Losing weight rapidly can negatively affect wrestlers' performance. Learn how to cut weight healthily for wrestling with our 8 tips in 2023 .
Nach dem bitteren Europa-Start richtete Urs Fischer einen Appell an das immer starke Kollektiv von Union Berlin. Das unglückliche 1:3 (0:1) in der Conference